Condition: Hypertension · Vascular Diseases · Cardiovascular Diseases · Sponsor: Medtronic Vascular
The purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural approach used in the SPYRAL HTN-ON MED and SPYRAL PIVOTAL - SPYRAL HTN-OFF MED clinical studies in an uncontrolled hypertensive population.
This description comes directly from the study's public registry record.
Kelsey Anderson · 651 247 5268 · rs.spyralaffirm@medtronic.com
Carly Loudoun · +31 43 356 6566 · rs.spyralaffirm@medtronic.com
Always discuss trial participation with your own doctor first.
| The Alfred Hospital | Melbourne, Australia | Recruiting |
| Royal Perth Hospital | Perth, Australia | Recruiting |
| Ziekenhuis Oost Limburg | Genk, Limburg, Belgium | Recruiting |
| CHC MontLégia | Liège, Liège, Belgium | Recruiting |
| Algemeen Stedelijk Ziekenhuis - Campus Aalst | Aalst, Belgium | Recruiting |
| AZ Sint Jan Brugge-Oostende av | Bruges, Belgium | Recruiting |
| Universitair Ziekenhuis Gent | Ghent, Belgium | Recruiting |
| Universitat des Saarlandes | Homburg, Saarland, Germany | Recruiting |
| Sana Kliniken Lübeck GmbH | Lübeck, Schleswig-Holstein, Germany | Recruiting |
| Universitätsklinikum Erlangen | Erlangen, Germany | Recruiting |
| Leipzig Heart Institute | Leipzig, Germany | Recruiting |
| Schwarzwald-Baar Klinikum Villingen-Schwenningen | Villingen-Schwenningen, Germany | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07115953